For years the U.S. Food and Drug Administration (FDA) has been after the American Red Cross to improve the way it collects and processes blood. Fifteen years ago they arrived at a settlement under court order that outlined how the American Red Cross would have to strengthen quality control and training, and improve its ability to identify, investigate and record problems. But, as detailed in the New York Times, only modest improvements have been made since that time.
As rightfully pointed out at the STATS blog, pharmaceutical companies would never be allowed the leeway that has been given to the American Red Cross. They failed to inform the FDA of their mistakes, let alone investigate the results of them, and as a results no one really knows how many serious health problems they are responsible for. As the old mantra goes: you can only manage what you measure.
Also disconcerting is that two-thirds of their revenue at the American Red Cross comes from blood services. But how much of that revenue goes back into blood services, or go to subsidize disaster-relief efforts? They don’t know, because of a antiquated financial systems.
Vampires in Canada
There are a lot of similarities between this story and Canada’s tainted blood scandal involving the Canadian Red Cross, which came to a head during public hearings fifteen years ago. The phrasing of the New York Times article suggests the Canadian Red Cross chose to break off its blood services operations, but they were forced out. The only choice they were given was whether to stay involved to help in promoting blood donations, but they decided to break all ties given the bad press and mismanagement.
The old blood services run by the Canadian Red Cross was plagued with non-professional committees that “took a long time to absorb new information.” But when Canadian Blood Services took over collection and distribution of blood products, Health Canada was put to the task of “strengthen[ing] the regulatory role with better resources, integrated data collection and analysis, and being more aggressive in raising standards.”
Health Canada organized a working group “to develop a plan and design a program for a comprehensive blood surveillance system for Canada.” The emphasis is clear from their final report in 1999—data collection and management. Previous focus was on data collection for operational rather than surveillance purposes. As a result of this focus, and a lack of standardization and integration between organizations and jurisdictions, a lot of important data was not being collected.
It’s time Americans demand their blood services be separated from the Red Cross and its bias towards disaster relief. Blood services should be managed by appropriately trained health professionals, with strong ties to federal regulators. Being at arms length from the government, yet closely tied with Heatlh Canada, has allowed Canadian Blood Services to increase standards in ways that could never have been achieved through the Red Cross.